About this Research Topic
COVID-19, an illness caused by the novel coronavirus SARS-CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has become increasingly apparent that it can also affect other organs, such as the brain. Patients with long COVID often report persistent symptoms, such as brain fog, mood changes, and dizziness, after the acute infection has resolved. These symptoms likely reflect neuroinflammation, an immune response to brain injury or infection. Research has shown that SARS-CoV-2 can cause neuroinflammation in the brain, causing persistent brain inflammation even after clearing the virus. Additionally, imaging studies have shown structural and functional changes in the brain of long COVID patients, indicating ongoing inflammation. The mechanisms underlying this link between COVID-19 and brain inflammation are still not fully understood, and research is ongoing to find effective therapies for long COVID symptoms. Understanding the mechanisms behind long COVID and neuroinflammation is crucial to developing targeted therapies that alleviate these symptoms.
The goal of ongoing research into the COVID-19 and neuroinflammation link is to develop targeted therapies to alleviate long-term COVID symptoms and improve the quality of life of those affected. It is hoped that researchers will be able to develop effective treatments to reduce brain inflammation and associated symptoms. Ultimately, the goal is to improve the health outcomes of long COVID patients and restore their physical and mental health.
1. The mechanisms behind the link between COVID-19 and neuroinflammation.
2. The prevalence and severity of neuroinflammation in patients with long COVID.
3. The use of imaging techniques to detect brain inflammation and changes in long COVID patients.
4. The use of mutiomoc techniques to Identify potential biomarkers that can be used to diagnose and monitor disease progression in long COVID patients with neuroinflammation.
5. The development of effective treatments for long COVID symptoms associated with neuroinflammation.
6. The potential long-term effects of neuroinflammation on cognitive function and mental health.
The goal of ongoing research into the COVID-19 and neuroinflammation link is to develop targeted therapies to alleviate long-term COVID symptoms and improve the quality of life of those affected. It is hoped that researchers will be able to develop effective treatments to reduce brain inflammation and associated symptoms. Ultimately, the goal is to improve the health outcomes of long COVID patients and restore their physical and mental health.
1. The mechanisms behind the link between COVID-19 and neuroinflammation.
2. The prevalence and severity of neuroinflammation in patients with long COVID.
3. The use of imaging techniques to detect brain inflammation and changes in long COVID patients.
4. The use of mutiomoc techniques to Identify potential biomarkers that can be used to diagnose and monitor disease progression in long COVID patients with neuroinflammation.
5. The development of effective treatments for long COVID symptoms associated with neuroinflammation.
6. The potential long-term effects of neuroinflammation on cognitive function and mental health.
Keywords: Long COVID, Brain inflammation, Neuroinflammation, SARS-CoV-2, Mechanisms, Pathogenesis, symptoms, Imaging studies, Therapy, Treatment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
